Feirza 1/20 Shortage Update: What Patients Need to Know in 2026

If you've had trouble filling your Feirza 1/20 prescription and are wondering whether there's an official shortage to blame, this article gives you the latest 2026 status — including what the FDA says, why local stock gaps still happen even without a formal shortage, and what you need to do to protect your contraceptive continuity right now.

Is There a Feirza 1/20 Shortage in 2026?

As of 2026, there is no FDA-declared national drug shortage of Feirza 1/20 or its active ingredient class (norethindrone acetate / ethinyl estradiol / ferrous fumarate). The FDA's drug shortage database does not list this combination as a current shortage. This is good news for patients, but it doesn't mean every pharmacy has it on the shelf at all times.

Feirza 1/20 is manufactured by Xiromed LLC (NDC 70700-307) and entered the market in January 2025. As a relatively new brand in a crowded generic class, it may not yet be part of every pharmacy's standard ordering inventory. This creates localized stock gaps — your pharmacy doesn't have it today, even though other pharmacies in your city do.

What Is the FDA Drug Shortage Process?

The FDA officially declares a drug shortage when a medically necessary drug cannot meet patient demand on a national level. Manufacturers are required to notify the FDA at least 6 months before a discontinuation or interruption in supply. When a shortage is declared, the FDA works with manufacturers to resolve it and publishes updates on its shortage database at fda.gov/drugs/drug-shortages.

For oral contraceptives as a class — including norethindrone/ethinyl estradiol formulations — there is no active FDA shortage listing as of 2026. The generic class is broadly well-supplied with multiple manufacturers (Xiromed, Allergan, Afaxys, Aurobindo, Mayne Pharma, and others) producing equivalent products.

Why Are Some Pharmacies Out of Feirza 1/20?

Even without a national shortage, stock gaps happen at the individual pharmacy level. Common causes include:

New brand, building distribution: Feirza 1/20 was introduced in January 2025. Not all pharmacies have added it to their standard formulary ordering cycle yet.

Wholesaler allocation: Pharmacies order from regional drug wholesalers (McKesson, AmerisourceBergen, Cardinal Health), and specific brands may be in short supply from a given wholesaler.

Insurance-driven brand preferences: Pharmacies stock what their patient population most often receives coverage for. If Feirza 1/20 isn't widely on insurance formularies in your area, the pharmacy may not order it in quantity.

Temporary supply chain delays: Manufacturing timelines, shipping delays, and API (active pharmaceutical ingredient) sourcing can all cause transient stock gaps.

Historic Context: Have Oral Contraceptives Ever Been in Shortage?

Oral contraceptives as a class have been relatively resilient to major national shortages. However, specific brands and formulations have occasionally faced regional stock gaps, especially during periods of high demand (such as following policy changes affecting contraceptive access) or manufacturing facility disruptions. The wide availability of therapeutically equivalent generics means patients have more fallback options than they would with a shortage of a medication that has no equivalent substitute.

What Should You Do Right Now to Protect Your Prescription?

Whether or not there's a formal shortage, here are the steps to take if you're having trouble finding Feirza 1/20:

Check your current supply — if you have fewer than 7 days of pills left, contact your prescriber today.

Call multiple pharmacies. Ask specifically for Feirza 1/20, 28-day pack. Stock varies widely even within blocks of each other.

Use medfinder — medfinder calls pharmacies near you to check stock and texts you the results.

Ask your prescriber for a bridging prescription for an equivalent generic (Junel Fe 1/20, Blisovi Fe 1/20, etc.) if Feirza isn't available at any nearby pharmacy.

Consider switching to mail-order pharmacy for future refills to avoid recurring stock gaps.

Monitoring Future Shortage Status

You can check the official FDA drug shortage database at fda.gov/drugs/drug-shortages to see if any shortage has been declared for norethindrone acetate/ethinyl estradiol products. The American Society of Health-System Pharmacists (ASHP) also maintains a drug shortage resource at ashp.org. These are the most authoritative sources for shortage information.

The Bottom Line

As of 2026, Feirza 1/20 is not in a declared national shortage, but localized stock gaps are real and can impact your ability to fill your prescription on time. The good news: this is a well-supported drug class with many equivalent alternatives. See our full guide to Feirza 1/20 alternatives if you need a bridge option while you locate your preferred brand.